BIODYNE's largest shareholder Ukbin Im increases stake to 43.37% via open market purchases, adds two special relations
BIODYNE's largest shareholder and CEO Ukbin Im increased his voting shares by 102,366 shares through open market purchases, raising his stake from 43.02% to 43.37%.
Two new special relations, Im Dahyeok and Im Dain, were added, each acquiring a small number of shares through open market purchases.
Existing call option and pledge agreements with institutional investors such as Woori Bank and Eugene Asset Management remain unchanged, supporting governance stability.
[AI Summary]The largest shareholder's minor stake increase reflects confidence in management but has limited direct impact on stock price. The addition of special relations and maintained institutional contracts enhance governance stability.